Ensysce Biosciences (ENSC) Liabilities and Shareholders Equity (2017 - 2025)
Ensysce Biosciences (ENSC) recorded Liabilities and Shareholders Equity of $7.45 million in Q4 2025, up 33.1% from $5.6 million a year earlier and up 134.4% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Liabilities and Shareholders Equity (2017 - 2025) Analysis & Trends
Starting with Q4 2017, Ensysce Biosciences' Liabilities and Shareholders Equity history includes 33 quarters.
- Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of 84.2% (FY2020 to FY2025).
- Across earlier years, Liabilities and Shareholders Equity came in at $5.6 million in FY2024 (+106.7%), $2.71 million in FY2023 (-54.0%), $5.89 million in FY2022 (-64.2%) and $16.42 million in FY2021.
- The Q4 2025 figure is the highest quarterly Liabilities and Shareholders Equity since Q3 2024.
- On a year-over-year basis, Liabilities and Shareholders Equity rose in five of the last eight quarters, with growth averaging 41.1%.
- Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 191.6% in Q3 2024, against a decline of 78.9% in Q1 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.18 million (Q3 2025), $5.57 million (Q2 2025) and $4.61 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.06 Bn | 1,133.65 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 643.87 Bn | 563.73 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 501.19 Bn | 474.31 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 357.68 Bn | 312.06 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 301.88 Bn | 265.87 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 267.25 Bn | 240.94 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 241.08 Bn | 196.48 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 192.57 Bn | 166.76 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 171.48 Bn | 118.13 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Ensysce Biosciences | 1.33 Mn | -9.91 Mn | - | 7.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 7.45 Mn |
| Sep 30, 2025 | 3.18 Mn |
| Jun 30, 2025 | 5.57 Mn |
| Mar 31, 2025 | 4.61 Mn |
| Dec 31, 2024 | 5.60 Mn |
| Sep 30, 2024 | 9.38 Mn |
| Jun 30, 2024 | 2.80 Mn |
| Mar 31, 2024 | 5.07 Mn |
| Dec 31, 2023 | 2.71 Mn |
| Sep 30, 2023 | 3.22 Mn |
| Jun 30, 2023 | 6.36 Mn |
| Mar 31, 2023 | 3.91 Mn |
| Dec 31, 2022 | 5.89 Mn |
| Sep 30, 2022 | 8.29 Mn |
| Jun 30, 2022 | 7.95 Mn |
| Mar 31, 2022 | 12.37 Mn |
| Dec 31, 2021 | 16.42 Mn |
| Sep 30, 2021 | 9.72 Mn |
| Jun 30, 2021 | 9.20 Mn |
| Mar 31, 2021 | 12.98 Mn |
API Access
Ensysce Biosciences Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();